Epigenetic reprograming in ATM-deficient pancreatic cancer: targeting EZH2-mediated oncogenic traits

被引：0
|
作者：
Roger, Elodie
Harle, Anna
Perkhofer, Lukas
Hessmann, Elisabeth
Kleger, Alexander
Gout, Johann
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 17期
关键词：
D O I：
10.1158/1538-7445.PANCREATIC24-B088
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B088
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells
    Sun, Feng
    Chan, Eli
    Wu, Zhenlong
    Yang, Xiaojing
    Marquez, Victor E.
    Yu, Qiang
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12) : 3191 - 3202
  • [32] EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
    Shih, C-H
    Chang, Y-J
    Huang, W-C
    Jang, T-H
    Kung, H-J
    Wang, W-C
    Yang, M-H
    Lin, M-C
    Huang, S-F
    Chou, S-W
    Chang, E.
    Chiu, H.
    Shieh, T-Y
    Chen, Y-J
    Wang, L-H
    Chen, L.
    ONCOGENE, 2017, 36 (47) : 6542 - 6554
  • [33] EZH2-mediated upregulation of ROS1 oncogene promotes oral cancer metastasis
    C-H Shih
    Y-J Chang
    W-C Huang
    T-H Jang
    H-J Kung
    W-C Wang
    M-H Yang
    M-C Lin
    S-F Huang
    S-W Chou
    E Chang
    H Chiu
    T-Y Shieh
    Y-J Chen
    L-H Wang
    L Chen
    Oncogene, 2017, 36 : 6542 - 6554
  • [34] CBX2 enhances the progression and TMZ chemoresistance of glioma via EZH2-mediated epigenetic silencing of PTEN expression
    Wang, Jian
    Yang, Bo
    Wang, Yingzhao
    Liu, Shuhan
    Ma, Changkai
    Piao, Jianmin
    Ma, Shiqiang
    Yu, Dehai
    Wu, Wei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [35] Targeting epigenetic dysregulation in bladder cancer through inhibition of EZH2.
    Keller, Patricia J.
    Meyer, Rosana
    Greenwald, Emily
    Han, Xinwei
    Conery, Andrew R.
    Mertz, Jennifer A.
    Trojer, Patrick
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 40 - 40
  • [36] EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
    Au, Sandy Leung-Kuen
    Wong, Carmen Chak-Lui
    Lee, Joyce Man-Fong
    Wong, Chun-Ming
    Ng, Irene Oi-Lin
    PLOS ONE, 2013, 8 (06):
  • [37] Retinoic acid (RA) relieves EZH2-mediated epigenetic suppression in high-risk neuroblastoma (HR-NB)
    Banerjee, Deblina
    Liu, Zhihui
    Oh, Doo-Yi
    Cam, Maggie
    Kim, Bong-Hyun
    Thiele, Carol
    CANCER RESEARCH, 2017, 77
  • [38] EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression
    Zhao, Kun
    He, Jing
    Wang, Yan-fen
    Jin, Shi-dai
    Fan, Yu
    Fang, Na
    Qian, Jun
    Xu, Tong-peng
    Guo, Ren-hua
    GENE, 2019, 686 : 118 - 124
  • [39] ATM-deficient lung, prostate and pancreatic cancer cells are acutely sensitive to the combination of olaparib and the ATR inhibitor AZD6738
    Nicholas R. Jette
    Suraj Radhamani
    Ruiqiong Ye
    Yaping Yu
    Greydon Arthur
    Siddhartha Goutam
    Tarek A. Bismar
    Mehul Kumar
    Pinaki Bose
    Steven Yip
    Michael Kolinsky
    Susan P. Lees-Miller
    Genome Instability & Disease, 2020, 1 (4) : 197 - 205
  • [40] Maintenance Therapy for ATM-Deficient Pancreatic Cancer by Multiple DNA Damage Response Interferences after Platinum-Based Chemotherapy
    Roger, Elodie
    Gout, Johann
    Arnold, Frank
    Beutel, Alica K.
    Mueller, Martin
    Abaei, Alireza
    Barth, Thomas F. E.
    Rasche, Volker
    Seufferlein, Thomas
    Perkhofer, Lukas
    Kleger, Alexander
    CELLS, 2020, 9 (09)
12345